Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Emed Technologies Corporation — Predicate Candidate Screening

11 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

142 daysmedian FDA review time
364 days90th percentile
11clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K251105Tetra (TM-20); Tetra (TM-50)Emed Technologies Corporation2025-12-222550
K240148SCIg60 Infusion SystemEmed Technologies Corporation2024-02-16280
K230883VersaPump Infusion SystemEmed Technologies Corporation2023-11-282430
K213429AccuSert Needle InserterEmed Technologies Corporation2022-10-203640
K222087SCIg60 Infusion SystemEmed Technologies Corporation2022-10-13900
K173783SCIg60 Infusion SystemEmed Technologies Corporation2018-12-143660
K161906SCIg60 InfuserEmed Technologies Corporation2016-12-011420
K142319SCIg60 Infuser, InfusetEmed Technologies Corporation2015-05-142670
K140133INFUSET FLOW CONTROL EXTENSION SETEmed Technologies Corporation2014-05-151180
K140131SUB-Q SUBCUTANEOUS TISSUE INFUSION SETEmed Technologies Corporation2014-04-03760
K123729VERSARATE FLOW RATE CONTROLEREmed Technologies Corporation2012-12-21160

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda